Comera Life Sciences Holdings, Inc. (CMRA): Price and Financial Metrics
CMRA Price/Volume Stats
| Current price | $0.00 | 52-week high | $0.37 |
| Prev. close | $0.00 | 52-week low | $0.00 |
| Day low | $0.00 | Volume | 300 |
| Day high | $0.00 | Avg. volume | 17,732 |
| 50-day MA | $0.03 | Dividend yield | N/A |
| 200-day MA | $0.12 | Market Cap | 3.07K |
CMRA Stock Price Chart Interactive Chart >
Comera Life Sciences Holdings, Inc. (CMRA) Company Bio
Comera Life Sciences Holdings, Inc. operates as a pre-clinical biotechnology company. It develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. The company's SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. Its products pipeline include CLS-001, an SQ formulation of a marketed, IV administered monoclonal antibody therapeutic for Crohn's disease and ulcerative colitis; CLS-002, an SQ formulation of a marketed, IV-administered immuno-oncology targeted monoclonal antibody for various oncology indications. The company was founded in 2014 and is based in Woburn, Massachusetts.
CMRA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | 0.00% |
| 1-year | 0.00% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 0.00% |
| 2023 | -95.53% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...